London, UK (PRWEB) March 16, 2010
Model N, the leader in Revenue Management solutions for global Life Science organisations, and a leading international medical device manufacturer will discuss proven strategies for maximizing sales performance with Revenue Management at this week's MDDEXEC Sales and Marketing Excellence Europe 2010 Conference at the Regent's Park Marriott in London.
The presentation will explore how rapidly growing Model N is providing international medical device companies with holistic Revenue Management solutions that increase global margin visibility in both direct and indirect channels, manage free goods and services against margin needs, and empower organisations to turn information into insight and income.
Session: Maximizing Sales Performance with Revenue Management: Managing Pricing, Contracting, Strategy, and Execution For Higher Net Price and Margin Achievement
Speakers: Sujay Jadhav, Life Sciences Vice President and General Manager, Model N; Niels Skov, Managing Director, Model N UK; Medical Device Industry Special Guest
Time: 14:30 17 March 2010
Location: Sales and Marketing Excellence Europe 2010, Regent's Park Marriott, London
About Model N
Model N is the leader in Revenue Management solutions for the global Life Science industry. The company offers a holistic end-to-end revenue life cycle vision and a suite of Revenue Management solution applications including Price Strategy and Execution, Price Management Analytics, Contracting, Bid and Tender Management, Rebates, and Channel Management, all purpose built for the industry practices of global Life Science companies. By enabling a seamless end-to-end process from price setting through net price and margin achievement, Model N's uniquely integrated approach eliminates revenue leakage and delivers the visibility and controls needed to enhance organisational pricing discipline for margin optimization across diverse and disparate market locations. Model N customers include Boston Scientific; ConMed; Medtronic; Ortho-Clinical Diagnostics, a Johnson & Johnson company; CR Bard; Hospira; Par Pharmaceuticals; Amgen; Novartis; Pfizer; Abbott; Bristol-Myers Squibb; and others. Model N is headquartered in Redwood Shores, USA, and has European offices in London, UK, and Zurich, Switzerland. For additional information, please visit http://www.modeln.com.
# # #